Germantown, MD, United States of America

Mei-Ling Liou

USPTO Granted Patents = 18 (Patent Applications = 2)

EPO Patents = 2 (Patent Applications = 5)

Average Co-Inventor Count = 4.1

ph-index = 7

Forward Citations = 186(Granted Patents)

Location History:

Germantown, MD (US) (2017 - 2022)
Rockville, MD (US) (2020 - 2022)

Company Filing History:

16 out of 34

American Gene Technologies International Inc.

1 out of 833,002

Other

patents

Years Active: 2017-2025

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12410446 - Methods and compositions for the activation of gamma-delta T-cells (2025-09-09),

2. 12403155 - Methods and compositions for the activation of gamma-delta T-cells (2025-09-02),

3. 12359203 - Combination vectors and methods for treating cancer (2025-07-15),

4. 11534450 - Methods and compositions for the activation of gamma-delta T-cells (2022-12-27),

5. 11519006 - Methods and compositions for the activation of gamma-delta T-cells (2022-12-06),

6. 11242527 - Combination vectors and methods for treating cancer (2022-02-08),

7. 10975374 - Combination vectors and methods for treating cancer (2021-04-13),

8. 10772905 - Methods and compositions for the activation of gamma-delta T-cells (2020-09-15),

9. 10767183 - Combination vectors and methods for treating cancer (2020-09-08),

10. 10472649 - Methods and compositions for the activation of gamma-delta T-cells (2019-11-12),

11. 10428350 - Methods and compositions for the activation of gamma-delta T-cells (2019-10-01),

12. 10420789 - Methods and compositions for the activation of gamma-delta T-cells (2019-09-24),

13. 10137144 - Methods and compositions for the activation of gamma-delta T-cells (2018-11-27),

14. 10036040 - Methods and compositions for the activation of gamma-delta T-cells (2018-07-31),

15. 10023880 - Methods and compositions for the activation of gamma-delta T-cells (2018-07-17),

Title: **Innovations by Mei-Ling Liou: A Pioneer in Immunotherapy**

Introduction

Mei-Ling Liou, a prominent inventor based in Germantown, MD, has made significant contributions to the field of immunotherapy through her innovative research and development of gene therapy methods. With a total of 15 patents to her name, her work has the potential to impact the treatment landscape for various cancers and infectious diseases.

Latest Patents

Among her latest inventions, Mei-Ling Liou has developed methods and compositions for the activation of gamma-delta T-cells. These inventions focus on harnessing gamma delta T-cells for gene therapy and immunotherapy, representing a breakthrough in the treatment of a range of diseases. These methodologies aim to provide new avenues for combating serious health conditions, showcasing her commitment to advancing medical science.

Career Highlights

Throughout her career, Mei-Ling has collaborated with influential organizations such as American Gene Technologies International Inc. Her experience with such a reputable company underscores her expertise in the field of genetic research and its practical applications in therapy.

Collaborations

Mei-Ling has worked alongside notable colleagues including Charles David Pauza and Haishan Li. These collaborations highlight her ability to work within a team of dedicated professionals to push the boundaries of biotechnology and immunological research.

Conclusion

In conclusion, Mei-Ling Liou stands out as an innovative inventor in the realm of immunotherapy and gene therapy. With her 15 patents and pivotal contributions to the field, she continues to play a crucial role in developing methodologies that have the potential to change lives. Her work not only reflects her passion for invention but also her commitment to addressing some of the most challenging health issues of our time.

This text is generated by artificial intelligence and may not be accurate.